Priority Date: 15.06.11 (EP 20110305748)

POLYPEPTIDES ISOLATED FROM BREVIBACTERIUM AURANTIACUM AND THEIR USE FOR THE TREATMENT OF CANCER

  • Application ID: EP12729514
  • Status: GRANT OF PATENT INTENDED

Attorneys

no operation time available
1262.32
4 offices
active in Legal Services
no operation time available
Headquarter in Paris
Technology Transfer Office

Specialization

This EP application has the IPC class C07 (ORGANIC CHEMISTRY). Lavoix and Inserm Transfert are specialized in C07. Lavoix, Inserm Transfert is specialised in C07 (ORGANIC CHEMISTRY). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 15.06.2011 - Priority Date (EP 20110305748)
  • 20.12.2012 - Publication A1 (WO2012172074)
  • 23.04.2014 - Publication A1 (EP2721057)

IPC Classification